Lista de obras - Alastair J Hutchison - Dominio Público Uruguay

A Multifaceted Quality Improvement Programme to Improve Acute Kidney Injury Care and Outcomes in a Large Teaching Hospital

artículo científico publicado en 2017

A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on D

artículo científico publicado en 2015

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

artículo científico publicado en 2003

A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis

artículo científico publicado en 2019

Acute arteriovenous access failure: long-term outcomes of endovascular salvage and assessment of co-variates affecting patency.

artículo científico publicado en 2015

Adequacy of calcium and phosphate balance in peritoneal dialysis

scientific article published on 01 January 1994

Angiomyolipoma in a transplanted kidney

artículo científico publicado en 1999

Association of sex hormone status with the bone loss of renal transplant patients

artículo científico publicado en 2001

Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis

artículo científico publicado en 1996

Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients

artículo científico publicado en 2003

Bone loss in long-term renal transplantation: histopathology and densitometry analysis

artículo científico publicado en 1999

Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy

scientific article published on 01 January 1999

Calcium and magnesium flux in automated peritoneal dialysis.

artículo científico publicado en 2009

Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid

scientific article published on 01 January 1993

Calcium content in automated peritoneal dialysis solutions.

artículo científico publicado en 1999

Cardiovascular disease in patients with chronic kidney disease

artículo científico publicado en 2009

Comparison of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis and hemodialysis

artículo científico publicado en 1993

Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study

artículo científico publicado en 2005

Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease

scientific article published on 01 November 1993

Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site

artículo científico publicado en 2004

Dialysis therapies for end-stage renal disease.

artículo científico publicado en 2002

Dissolution of extensive urolithiasis: extending the utility of rasburicase can avoid the need for surgical intervention and renal replacement therapy.

artículo científico publicado en 2016

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

artículo científico publicado en 2000

Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation

artículo científico publicado en 2000

Effect of long-term therapy with 1.25 mmol/L calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPD

artículo científico publicado en 1992

Effect of radiotherapy on peritoneal function in continuous ambulatory peritoneal dialysis

artículo científico publicado en 1993

Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate

artículo científico publicado en 2005

Enabling self-management: selecting patients for home dialysis?

artículo científico publicado en 2011

Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy.

artículo científico publicado en 2008

Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients

artículo científico publicado en 1994

Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations

artículo científico publicado en 1996

Hyperphosphataemia in 2019: have we made progress?

scientific article published on 01 September 2019

Hyperphosphataemia in renal failure: causes, consequences and current management

artículo científico publicado en 2003

Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers

artículo científico publicado el 1 de octubre de 1992

Improving phosphate-binder therapy as a way forward.

artículo científico publicado en 2004

Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust

artículo científico publicado en 2014

Increased mortality due to cardiovascular disease in type 1 diabetic patients transplanted for end-stage renal failure

scientific article published on 01 December 1994

Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients.

artículo científico publicado en 2009

Lanthanum and phosphate: science, policy, and survival

scientific article published on February 2009

Lanthanum carbonate for hyperphosphatemia in patients with advanced CKD and patients receiving dialysis

scientific article published on 01 July 2009

Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients.

artículo científico publicado en 2005

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

artículo científico publicado en 2013

Lanthanum carbonate--a first line phosphate binder?

artículo científico publicado en 2007

Lanthanum carbonate: safety data after 10 years

artículo científico publicado en 2016

Lanthanum data in perspective

scientific article published on 01 October 2006

Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate

article

Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment

article by Alastair J Hutchison et al published 2008 in Nephron Clinical Practice

Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study

artículo científico publicado en 2005

Low turnover bone disease.

artículo científico publicado en 1996

Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia ⬇️

artículo científico publicado el 1 de enero de 1992

Macroglossia and amyloidoma of the buttock: evidence of systemic involvement in dialysis amyloid

scientific article published on 01 January 1990

Malnutrition and refeeding syndrome associated with encapsulating peritoneal sclerosis

artículo científico publicado en 2007

Monitoring and management of patients on therapeutic anticoagulation: A quality improvement initiative

artículo científico publicado en 2019

Novel phosphate binders: plus ça change, plus c'est la même chose

artículo científico publicado en 2014

Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis

artículo científico publicado en 2008

Oral phosphate binders

artículo científico publicado en 2009

Oral phosphate binders for the management of serum phosphate levels in dialysis patients

artículo científico publicado en 2009

Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis

artículo científico publicado en 2014

Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitis

artículo científico publicado en 1996

Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis

artículo científico publicado en 2001

Pharmacology, efficacy and safety of oral phosphate binders

artículo científico publicado en 2011

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.

artículo científico publicado en 2008

Prescribing high-quality peritoneal dialysis: Moving beyond urea clearance

artículo científico publicado en 2020

Profiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence support

artículo científico publicado en 2014

Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'.

artículo científico publicado en 2007

Quality of life in CAPD, transplant, and chronic renal failure patients with diabetes

artículo científico publicado en 2007

Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis

artículo científico publicado en 1999

Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure

artículo científico publicado en 2001

Reduced calcium dialysis fluids: what's the point?

scientific article published on 01 May 1996

Reducing dialysate calcium - a reasonable strategy?

artículo científico publicado en 2004

Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate

artículo científico publicado en 2004

Renal osteodystrophy in CAPD.

artículo científico publicado en 1991

Risk factors for non-ischaemic foot ulceration in diabetic nephropathy

artículo científico publicado en 1991

Severe acute renal failure in adults: place of care, incidence and outcomes

artículo científico publicado en 2005

Side-effects of antituberculosis drug treatment in patients with chronic renal failure

artículo científico publicado en 2002

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.

artículo científico publicado en 2005

Small intestinal infarction: a fatal complication of systemic oxalosis

artículo científico publicado en 2000

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

artículo científico publicado en 2008

The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis.

artículo científico publicado en 1992

The repositioning of migrated Tenckhoff continuous ambulatory peritoneal dialysis catheters under fluoroscopic control

artículo científico publicado en 1999

Update and critical appraisal of sevelamer in the management of chronic renal failure

artículo científico publicado en 2010

Use of magnesium as a drug in chronic kidney disease

artículo científico

Use of oral stable strontium to provide an index of intestinal calcium absorption in chronic ambulatory peritoneal dialysis patients

artículo científico publicado en 1992

Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients

artículo científico publicado en 2013

Vitamin D therapy in CAPD: what is its role?

scientific article published on 01 January 1993

Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?

artículo científico publicado en 2007

Lista de obras de Alastair J Hutchison

A Multifaceted Quality Improvement Programme to Improve Acute Kidney Injury Care and Outcomes in a Large Teaching Hospital

A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on D

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis

Acute arteriovenous access failure: long-term outcomes of endovascular salvage and assessment of co-variates affecting patency.

Adequacy of calcium and phosphate balance in peritoneal dialysis

Angiomyolipoma in a transplanted kidney

Association of sex hormone status with the bone loss of renal transplant patients

Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis

Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients

Bone loss in long-term renal transplantation: histopathology and densitometry analysis

Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy

Calcium and magnesium flux in automated peritoneal dialysis.

Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid

Calcium content in automated peritoneal dialysis solutions.

Cardiovascular disease in patients with chronic kidney disease

Comparison of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis and hemodialysis

Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study

Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease

Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site

Dialysis therapies for end-stage renal disease.

Dissolution of extensive urolithiasis: extending the utility of rasburicase can avoid the need for surgical intervention and renal replacement therapy.

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation

Effect of long-term therapy with 1.25 mmol/L calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPD

Effect of radiotherapy on peritoneal function in continuous ambulatory peritoneal dialysis

Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate

Enabling self-management: selecting patients for home dialysis?

Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy.

Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients

Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations

Hyperphosphataemia in 2019: have we made progress?

Hyperphosphataemia in renal failure: causes, consequences and current management

Improved solutions for peritoneal dialysis: physiological calcium solutions, osmotic agents and buffers

Improving phosphate-binder therapy as a way forward.

Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust

Increased mortality due to cardiovascular disease in type 1 diabetic patients transplanted for end-stage renal failure

Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients.

Lanthanum and phosphate: science, policy, and survival

Lanthanum carbonate for hyperphosphatemia in patients with advanced CKD and patients receiving dialysis

Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients.

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

Lanthanum carbonate--a first line phosphate binder?

Lanthanum carbonate: safety data after 10 years

Lanthanum data in perspective

Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate

Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment

Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study

Low turnover bone disease.

Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia ⬇️

Macroglossia and amyloidoma of the buttock: evidence of systemic involvement in dialysis amyloid

Malnutrition and refeeding syndrome associated with encapsulating peritoneal sclerosis

Monitoring and management of patients on therapeutic anticoagulation: A quality improvement initiative

Novel phosphate binders: plus ça change, plus c'est la même chose

Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis

Oral phosphate binders

Oral phosphate binders for the management of serum phosphate levels in dialysis patients

Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis

Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitis

Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis

Pharmacology, efficacy and safety of oral phosphate binders

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.

Prescribing high-quality peritoneal dialysis: Moving beyond urea clearance

Profiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence support

Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'.

Quality of life in CAPD, transplant, and chronic renal failure patients with diabetes

Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis

Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure

Reduced calcium dialysis fluids: what's the point?

Reducing dialysate calcium - a reasonable strategy?

Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate

Renal osteodystrophy in CAPD.

Risk factors for non-ischaemic foot ulceration in diabetic nephropathy

Severe acute renal failure in adults: place of care, incidence and outcomes

Side-effects of antituberculosis drug treatment in patients with chronic renal failure

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.

Small intestinal infarction: a fatal complication of systemic oxalosis

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis.